Skip to content
StockMarketAgent
Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

KOSDAQ/237690 stock hub

KOSDAQ/237690 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/237690is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.3T
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/237690
In the news

Latest news · KOSDAQ/237690

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E44.8
P25 9.8P50 17.1P75 31.9
Trailing P/E58
P25 12P50 23.1P75 39.5
ROE10
P25 -17.1P50 0.7P75 8.5
ROIC9.3
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/237690 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
223
Groups with data
11
Currency
KRW
Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
655
Enterprise value
KRW 3.2T
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Medical - Pharmaceuticals
Isin
KR7237690003
Last refreshed
2026-05-10
Market cap
KRW 3.3T
Price
KRW 156,000
Price currency
KRW
Rev Per Employee
506,383,637.31x
Sector
Healthcare
Sic
2833
Symbol
kosdaq/237690
Website
https://www.stpharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
1.69%
EV Earnings
58.9x
EV/EBIT
58.96x
EV/EBITDA
38.19x
EV/FCF
-97.91x
EV/Sales
9.77x
FCF yield
-1.02%
Forward P/E
44.79x
P/B ratio
5.48x
P/E ratio
58.03x
P/S ratio
9.8x
PE Ratio10 Y
103.34x
PE Ratio3 Y
66.44x
PE Ratio5 Y
147.61x
PEG ratio
1.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
16.56%
EBITDA Margin
25.57%
Gross margin
39.92%
Gross Profit
KRW 132.4B
Gross Profit Growth
41.46%
Gross Profit Growth Q
19.69%
Gross Profit Growth3 Y
14.95%
Gross Profit Growth5 Y
48.48%
Net Income
KRW 55B
Net Income Growth
58.42%
Net Income Growth Q
140.81%
Net Income Growth Quarters
3%
Net Income Growth Years
6%
Net Income Growth3 Y
45.1%
Pretax Margin
17.7%
Profit Margin
16.58%
Profit Per Employee
KRW 84M
Profitable Years
5
ROA
4.56
Roa5y
2.65
ROCE
8.89
ROE
9.96
Roe5y
5.68
ROIC
9.3
Roic5y
5.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

18
MetricValue
Cagr1y
108.76%
Cagr3y
20.01%
Cagr5y
7.47%
Div CAGR3
0%
Div CAGR5
0%
EPS Growth
51.05
EPS Growth Q
122.1
EPS Growth Quarters
3
EPS Growth Years
6
EPS Growth3 Y
41.1
OCF Growth
-87.22%
OCF Growth3 Y
25.77%
Revenue Growth
21.16x
Revenue Growth Q
11.55x
Revenue Growth Quarters
4x
Revenue Growth Years
1x
Revenue Growth3 Y
9.98x
Revenue Growth5 Y
21.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
KRW 0.44
Assets
KRW 782.6B
Cash
KRW 91B
Current Assets
KRW 372.7B
Current Liabilities
KRW 164.8B
Debt
KRW 78.7B
Debt EBITDA
KRW 0.93
Debt Equity
KRW 0.13
Debt FCF
KRW -2.38
Equity
KRW 593B
Interest Coverage
13.61
Liabilities
KRW 189.6B
Long Term Assets
KRW 409.9B
Long Term Liabilities
KRW 24.8B
Net Cash
KRW 12.3B
Net Cash By Market Cap
KRW 0.38
Net Cash Growth
341.27%
Net Debt EBITDA
KRW -0.14
Net Debt Equity
KRW -0.02
Tangible Book Value
KRW 576.4B
Tangible Book Value Per Share
KRW 27,845
WACC
5.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.26
Inventory Turnover
1.34
Net Working Capital
KRW 194.7B
Quick ratio
1.15
Working Capital
KRW 207.9B
Working Capital Turnover
KRW 1.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-9.95%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
KRW 500
Dividend Years
1
Dividend Yield
0.32%
Ex Div Date
2026-03-30
Last Dividend
KRW 500
Payout Ratio
18.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
108.66%
200-day SMA
119,301
3Y total return
72.86%
50-day SMA
150,004
50-day SMA vs 200-day SMA
50over200
5Y total return
43.36%
All Time High
172,100
All Time High Change
-9.36%
All Time High Date
2026-04-28
All Time Low
12,300
All Time Low Change
1,168.29%
All Time Low Date
2019-08-06
ATR
8,226.2
Beta
0.3
Beta1y
0.19
Beta2y
0.45
Ch YTD
30.87
High
159,800
High52
172,100
High52 Date
2026-04-28
High52ch
-9.36%
Low
154,100
Low52
70,800
Low52 Date
2025-05-19
Low52ch
120.34%
Ma50ch
4%
Price vs 200-day SMA
30.76%
RSI
54.47
RSI Monthly
70.56
RSI Weekly
60.67
Sharpe ratio
1.51x
Sortino ratio
2.61
Total Return
-9.63%
Tr YTD
31.29
Tr1m
13.87%
Tr1w
1.43%
Tr3m
6.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
KRW 54.9B
Operating Income Growth
98.37
Operating Income Growth Q
15.31
Operating Income Growth3 Y
45.45
Operating margin
16.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
13,117,298%
Net Borrowing
-9,421,038,490
Shares Insiders
7.36%
Shares Institutions
13.84%
Shares Out
20,843,927
Shares Qo Q
14.58%
Shares Yo Y
9.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
KRW -34.6B
Average Volume
150,100.55x
Bv Per Share
28,666.4
CAPEX
KRW -47.1B
Ch1m
13.87
Ch1w
1.43
Ch1y
108
Ch3m
6.34
Ch3y
69.94
Ch5y
39.66
Ch6m
62.84
Change
1.43%
Change From Open
0.52
Close
153,800
Days Gap
0.91
Depreciation Amortization
29,881,081,000
Dollar Volume
22,402,848,000
Earnings Date
2026-04-27
EBIT
KRW 54.9B
EBITDA
KRW 84.8B
EPS
KRW 2,688
F Score
5
FCF
KRW -33.1B
FCF EV Yield
-1.02x
FCF Per Share
KRW -1,587
Financing CF
-20,082,958,730
Fiscal Year End
December
Founded
1,983
Goodwill
11,807,992,000
Graham Number
41640.92121
Graham Upside
-73.31
Income Tax
KRW 4.2B
Investing CF
-26,325,858,700
Is Primary Listing
1
Last Earnings Date
2026-04-27
Last Report Date
2025-12-31
Lynch Fair Value
KRW 67,209
Lynch Upside
-56.92
Ma150
128,463.3
Ma150ch
21.44%
Ma20
149,410
Ma20ch
4.41%
Net CF
-32,859,136,100
Next Earnings Date
2026-07-27
Open
155,200
P OCF Ratio
232.4
Payment Date
2026-04-20
Position In Range
33.33
Ppne
359,333,842,800
Price Date
2026-05-08
Price EBITDA
KRW 38.34
Ptbv Ratio
5.64
Relative Volume
0.96x
Revenue
331,681,282,440x
SBC By Revenue
0.46x
Share Based Comp
1,541,579,000
Tax By Revenue
1.25x
Tax Rate
7.09%
Tr6m
63.35%
Volume
143,608
Z Score
7.09
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/237690 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.3%
$500 annual per share
Payout ratio
+18.3%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
0.0%
0 consecutive years of growth
Total shareholder yield
-9.6%
Next ex-dividend date: 2026-03-30
Performance

KOSDAQ/237690 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+108.7%
S&P 500 1Y: n/a
3Y total return
+72.9%
S&P 500 3Y: n/a
5Y total return
+43.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/237690?

Insider, institutional, and short-interest positioning.

Institutional ownership
+13.8%
Share of float held by funds and institutions
Insider ownership
+7.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+10.0%
Negative means the company is buying back shares.
Technical

KOSDAQ/237690 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
54.5
Neutral momentum band
Price vs 200-day MA
+30.8%
50/200-day relationship not available
Beta (5Y)
0.30
Less volatile than the market
Sharpe ratio
1.51
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/237690

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/237690 stock rating?

kosdaq/237690 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/237690 analysis?

The full report lives at /stocks/kosdaq/237690/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/237690?

The latest report frames kosdaq/237690 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/237690 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.